Avalon Trust Co Has $19.89 Million Holdings in Stryker Corporation $SYK

Avalon Trust Co boosted its position in Stryker Corporation (NYSE:SYK) by 20,080.0% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 60,540 shares of the medical technology company’s stock after purchasing an additional 60,240 shares during the quarter. Stryker comprises about 1.4% of Avalon Trust Co’s portfolio, making the stock its 24th biggest holding. Avalon Trust Co’s holdings in Stryker were worth $19,893,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of SYK. Norges Bank bought a new stake in shares of Stryker in the fourth quarter valued at approximately $1,822,272,000. Auto Owners Insurance Co boosted its holdings in shares of Stryker by 35,047.0% in the 4th quarter. Auto Owners Insurance Co now owns 2,914,741 shares of the medical technology company’s stock valued at $1,024,444,000 after purchasing an additional 2,906,448 shares in the last quarter. Wellington Management Group LLP increased its stake in shares of Stryker by 22.6% in the 4th quarter. Wellington Management Group LLP now owns 6,493,276 shares of the medical technology company’s stock valued at $2,282,192,000 after purchasing an additional 1,198,665 shares during the last quarter. Corient Private Wealth LLC increased its stake in shares of Stryker by 104.4% in the 2nd quarter. Corient Private Wealth LLC now owns 2,245,841 shares of the medical technology company’s stock valued at $887,525,000 after purchasing an additional 1,146,998 shares during the last quarter. Finally, Credit Agricole S A acquired a new position in shares of Stryker during the 3rd quarter worth $194,045,000. Institutional investors own 77.09% of the company’s stock.

Stryker Stock Up 4.5%

Shares of NYSE:SYK opened at $330.64 on Friday. The business has a fifty day simple moving average of $312.00 and a 200 day simple moving average of $336.94. The company has a quick ratio of 1.25, a current ratio of 2.11 and a debt-to-equity ratio of 0.62. The firm has a market cap of $126.76 billion, a P/E ratio of 38.27, a P/E/G ratio of 2.03 and a beta of 0.77. Stryker Corporation has a 12-month low of $281.00 and a 12-month high of $404.87.

Stryker (NYSE:SYK) last released its earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). Stryker had a net margin of 13.20% and a return on equity of 23.42%. The firm had revenue of $6.02 billion for the quarter, compared to analyst estimates of $6.34 billion. During the same period in the prior year, the company posted $2.84 EPS. The business’s revenue for the quarter was up 2.6% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Analysts predict that Stryker Corporation will post 14.98 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Investors of record on Tuesday, June 30th will be paid a dividend of $0.88 per share. The ex-dividend date of this dividend is Tuesday, June 30th. This represents a $3.52 annualized dividend and a yield of 1.1%. Stryker’s dividend payout ratio (DPR) is currently 40.74%.

Insiders Place Their Bets

In related news, Director Ronda E. Stryker sold 310,000 shares of the business’s stock in a transaction on Tuesday, May 26th. The shares were sold at an average price of $312.23, for a total transaction of $96,791,300.00. Following the transaction, the director owned 1,924,880 shares in the company, valued at $601,005,282.40. The trade was a 13.87% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, VP M Kathryn Fink sold 3,500 shares of Stryker stock in a transaction on Monday, May 11th. The shares were sold at an average price of $283.45, for a total transaction of $992,075.00. Following the completion of the sale, the vice president directly owned 177 shares of the company’s stock, valued at approximately $50,170.65. This trade represents a 95.19% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Over the last three months, insiders sold 323,264 shares of company stock worth $100,659,489. 4.60% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

SYK has been the subject of several recent analyst reports. Barclays reduced their price objective on Stryker from $469.00 to $394.00 and set an “overweight” rating on the stock in a research note on Monday, May 4th. Leerink Partners reduced their price target on shares of Stryker from $410.00 to $407.00 and set an “outperform” rating on the stock in a research note on Friday, June 5th. Wall Street Zen cut shares of Stryker from a “buy” rating to a “hold” rating in a research report on Saturday, May 16th. BTIG Research set a $371.00 price objective on shares of Stryker in a research note on Monday. Finally, Robert W. Baird set a $385.00 target price on shares of Stryker in a research report on Friday, May 1st. One equities research analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and six have given a Hold rating to the stock. According to MarketBeat.com, Stryker presently has a consensus rating of “Moderate Buy” and an average price target of $392.52.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.